|
|
|
Volumn 125, Issue 1349, 2012, Pages
|
|
Initial experience with dabigatran etexilate at Auckland City Hospital
a
b
a
a
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMIODARONE;
CLOPIDOGREL;
DABIGATRAN ETEXILATE;
GLYCOPROTEIN P;
WARFARIN;
ANTITHROMBIN;
BENZIMIDAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
BLEEDING;
CREATININE CLEARANCE;
DRUG BIOAVAILABILITY;
DRUG EXCRETION;
GASTROINTESTINAL HEMORRHAGE;
HEART ATRIUM FIBRILLATION;
HEMATOMA;
HEMATURIA;
HOSPITAL;
HUMAN;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
LETTER;
NEW ZEALAND;
RISK;
STROKE;
ADULT;
AGED;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL (TOPIC);
FEMALE;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
RETROSPECTIVE STUDY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTITHROMBIN PROTEINS;
ATRIAL FIBRILLATION;
BENZIMIDAZOLES;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HEMORRHAGE;
HOSPITALS, URBAN;
HUMANS;
MALE;
MIDDLE AGED;
NEW ZEALAND;
PATIENT SELECTION;
PYRIDINES;
RENAL INSUFFICIENCY;
RETROSPECTIVE STUDIES;
|
|
EID: 84858055719
PISSN: None
EISSN: 11758716
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (3)
|
|
References (8)
|
